OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
How has access to legal cannabis changed over time? An analysis of the cannabis retail market in Canada 2 years following the legalisation of recreational cannabis
Daniel T. Myran, Emiliyan Staykov, Nathan Cantor, et al.
Drug and Alcohol Review (2021) Vol. 41, Iss. 2, pp. 377-385
Closed Access | Times Cited: 56
Daniel T. Myran, Emiliyan Staykov, Nathan Cantor, et al.
Drug and Alcohol Review (2021) Vol. 41, Iss. 2, pp. 377-385
Closed Access | Times Cited: 56
Showing 1-25 of 56 citing articles:
Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies
Marco Solmi, Marco De Toffol, Jong Yeob Kim, et al.
BMJ (2023), pp. e072348-e072348
Open Access | Times Cited: 121
Marco Solmi, Marco De Toffol, Jong Yeob Kim, et al.
BMJ (2023), pp. e072348-e072348
Open Access | Times Cited: 121
The association between recreational cannabis legalization, commercialization and cannabis‐attributable emergency department visits in Ontario, Canada: an interrupted time–series analysis
Daniel T. Myran, Michael Pugliese, Peter Tanuseputro, et al.
Addiction (2022) Vol. 117, Iss. 7, pp. 1952-1960
Closed Access | Times Cited: 70
Daniel T. Myran, Michael Pugliese, Peter Tanuseputro, et al.
Addiction (2022) Vol. 117, Iss. 7, pp. 1952-1960
Closed Access | Times Cited: 70
The implementation and public health impacts of cannabis legalization in Canada: a systematic review
Wayne Hall, Daniel Stjepanović, Danielle Dawson, et al.
Addiction (2023) Vol. 118, Iss. 11, pp. 2062-2072
Open Access | Times Cited: 46
Wayne Hall, Daniel Stjepanović, Danielle Dawson, et al.
Addiction (2023) Vol. 118, Iss. 11, pp. 2062-2072
Open Access | Times Cited: 46
The association between physical availability of cannabis retail outlets and frequent cannabis use and related health harms: a systematic review
Nathan Cantor, Max Silverman, Adrienne Gaudreault, et al.
The Lancet Regional Health - Americas (2024) Vol. 32, pp. 100708-100708
Open Access | Times Cited: 19
Nathan Cantor, Max Silverman, Adrienne Gaudreault, et al.
The Lancet Regional Health - Americas (2024) Vol. 32, pp. 100708-100708
Open Access | Times Cited: 19
Changes in Incident Schizophrenia Diagnoses Associated With Cannabis Use Disorder After Cannabis Legalization
Daniel T. Myran, Michael Pugliese, Lyndsay D. Harrison, et al.
JAMA Network Open (2025) Vol. 8, Iss. 2, pp. e2457868-e2457868
Open Access | Times Cited: 4
Daniel T. Myran, Michael Pugliese, Lyndsay D. Harrison, et al.
JAMA Network Open (2025) Vol. 8, Iss. 2, pp. e2457868-e2457868
Open Access | Times Cited: 4
Unintentional Pediatric Cannabis Exposures After Legalization of Recreational Cannabis in Canada
Daniel T. Myran, Nathan Cantor, Yaron Finkelstein, et al.
JAMA Network Open (2022) Vol. 5, Iss. 1, pp. e2142521-e2142521
Open Access | Times Cited: 48
Daniel T. Myran, Nathan Cantor, Yaron Finkelstein, et al.
JAMA Network Open (2022) Vol. 5, Iss. 1, pp. e2142521-e2142521
Open Access | Times Cited: 48
Changes in Emergency Department Visits for Cannabis Hyperemesis Syndrome Following Recreational Cannabis Legalization and Subsequent Commercialization in Ontario, Canada
Daniel T. Myran, Rhiannon Roberts, Michael Pugliese, et al.
JAMA Network Open (2022) Vol. 5, Iss. 9, pp. e2231937-e2231937
Open Access | Times Cited: 43
Daniel T. Myran, Rhiannon Roberts, Michael Pugliese, et al.
JAMA Network Open (2022) Vol. 5, Iss. 9, pp. e2231937-e2231937
Open Access | Times Cited: 43
Access to legal cannabis market in Canada over the four years following non‐medical cannabis legalisation
Daniel T. Myran, Erik Loewen Friesen, Sarah Dickson, et al.
Drug and Alcohol Review (2023) Vol. 42, Iss. 5, pp. 1114-1119
Open Access | Times Cited: 31
Daniel T. Myran, Erik Loewen Friesen, Sarah Dickson, et al.
Drug and Alcohol Review (2023) Vol. 42, Iss. 5, pp. 1114-1119
Open Access | Times Cited: 31
Changes in Cannabis-Attributable Hospitalizations Following Nonmedical Cannabis Legalization in Canada
Daniel T. Myran, Adrienne Gaudreault, Lauren Konikoff, et al.
JAMA Network Open (2023) Vol. 6, Iss. 10, pp. e2336113-e2336113
Open Access | Times Cited: 25
Daniel T. Myran, Adrienne Gaudreault, Lauren Konikoff, et al.
JAMA Network Open (2023) Vol. 6, Iss. 10, pp. e2336113-e2336113
Open Access | Times Cited: 25
Association between non-medical cannabis legalization and emergency department visits for cannabis-induced psychosis
Daniel T. Myran, Michael Pugliese, Rhiannon Roberts, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 10, pp. 4251-4260
Closed Access | Times Cited: 24
Daniel T. Myran, Michael Pugliese, Rhiannon Roberts, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 10, pp. 4251-4260
Closed Access | Times Cited: 24
The impact of cannabis legalization for recreational purposes on youth: A narrative review of the Canadian experience
Dafna Sara Rubin-Kahana, Jean‐François Crépault, Justin Matheson, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 31
Dafna Sara Rubin-Kahana, Jean‐François Crépault, Justin Matheson, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 31
Acute care related to cannabis use during pregnancy after the legalization of nonmedical cannabis in Ontario
Daniel T. Myran, Rhiannon Roberts, Michael Pugliese, et al.
Canadian Medical Association Journal (2023) Vol. 195, Iss. 20, pp. E699-E708
Open Access | Times Cited: 19
Daniel T. Myran, Rhiannon Roberts, Michael Pugliese, et al.
Canadian Medical Association Journal (2023) Vol. 195, Iss. 20, pp. E699-E708
Open Access | Times Cited: 19
Legal sourcing of ten cannabis products in the Canadian cannabis market, 2019–2021: a repeat cross-sectional study
Elle Wadsworth, Vicki Rynard, Pete Driezen, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 17
Elle Wadsworth, Vicki Rynard, Pete Driezen, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 17
Changes in health harms due to cannabis following legalisation of non‐medical cannabis in Canada in context of cannabis commercialisation: A scoping review
Daniel T. Myran, Sameer Imtiaz, Lauren Konikoff, et al.
Drug and Alcohol Review (2022) Vol. 42, Iss. 2, pp. 277-298
Closed Access | Times Cited: 27
Daniel T. Myran, Sameer Imtiaz, Lauren Konikoff, et al.
Drug and Alcohol Review (2022) Vol. 42, Iss. 2, pp. 277-298
Closed Access | Times Cited: 27
The Impact of Cannabis Decriminalization and Legalization on Road Safety Outcomes: A Systematic Review
Sarah B. Windle, Peter Socha, José Ignacio Nazif‐Muñoz, et al.
American Journal of Preventive Medicine (2022) Vol. 63, Iss. 6, pp. 1037-1052
Closed Access | Times Cited: 26
Sarah B. Windle, Peter Socha, José Ignacio Nazif‐Muñoz, et al.
American Journal of Preventive Medicine (2022) Vol. 63, Iss. 6, pp. 1037-1052
Closed Access | Times Cited: 26
Cannabis-Involved Traffic Injury Emergency Department Visits After Cannabis Legalization and Commercialization
Daniel T. Myran, Adrienne Gaudreault, Michael Pugliese, et al.
JAMA Network Open (2023) Vol. 6, Iss. 9, pp. e2331551-e2331551
Open Access | Times Cited: 16
Daniel T. Myran, Adrienne Gaudreault, Michael Pugliese, et al.
JAMA Network Open (2023) Vol. 6, Iss. 9, pp. e2331551-e2331551
Open Access | Times Cited: 16
Cannabis consumers’ preferences for legal and illegal cannabis: evidence from a discrete choice experiment
Jin Xing, Yuyan Shi
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Jin Xing, Yuyan Shi
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
The effect of recreational cannabis legalization and commercialization on substance use, mental health, and injury: a systematic review
Madison Walker, Melissa Carpino, David Lightfoot, et al.
Public Health (2023) Vol. 221, pp. 87-96
Open Access | Times Cited: 12
Madison Walker, Melissa Carpino, David Lightfoot, et al.
Public Health (2023) Vol. 221, pp. 87-96
Open Access | Times Cited: 12
Distribution of legal retail cannabis stores in Canada by neighbourhood deprivation
Fathima Fataar, Pete Driezen, Akwasi Owusu‐Bempah, et al.
Journal of Cannabis Research (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 4
Fathima Fataar, Pete Driezen, Akwasi Owusu‐Bempah, et al.
Journal of Cannabis Research (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 4
Association of recreational cannabis legalization with changes in medical, illegal, and total cannabis expenditures in Canada
André J. McDonald, Alysha Cooper, Amanda Doggett, et al.
International Journal of Drug Policy (2025) Vol. 139, pp. 104793-104793
Open Access
André J. McDonald, Alysha Cooper, Amanda Doggett, et al.
International Journal of Drug Policy (2025) Vol. 139, pp. 104793-104793
Open Access
Interrupted time series analysis of Canadian legal cannabis sales during the COVID ‐19 pandemic
Michael J. Armstrong, Nathan Cantor, Brendan T. Smith, et al.
Drug and Alcohol Review (2022) Vol. 41, Iss. 5, pp. 1131-1135
Open Access | Times Cited: 17
Michael J. Armstrong, Nathan Cantor, Brendan T. Smith, et al.
Drug and Alcohol Review (2022) Vol. 41, Iss. 5, pp. 1131-1135
Open Access | Times Cited: 17
On offer to Ontario consumers three years after legalization: A profile of cannabis products, cannabinoid content, plant type, and prices
Felicia Tassone, Patricia Di Ciano, Yuxin Liu, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 10
Felicia Tassone, Patricia Di Ciano, Yuxin Liu, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 10
Cannabis-involvement in emergency department visits for self-harm following medical and non-medical cannabis legalization
Daniel T. Myran, Adrienne Gaudreault, Michael Pugliese, et al.
Journal of Affective Disorders (2024) Vol. 351, pp. 853-862
Open Access | Times Cited: 3
Daniel T. Myran, Adrienne Gaudreault, Michael Pugliese, et al.
Journal of Affective Disorders (2024) Vol. 351, pp. 853-862
Open Access | Times Cited: 3
Changes in population‐level alcohol sales after non‐medical cannabis legalisation in Canada
Michael J. Armstrong, Rachael MacDonald‐Spracklin, Jennifer Xiao, et al.
Drug and Alcohol Review (2025)
Open Access
Michael J. Armstrong, Rachael MacDonald‐Spracklin, Jennifer Xiao, et al.
Drug and Alcohol Review (2025)
Open Access
Cannabis involvement in posttraumatic stress disorder emergency department visits after cannabis legalization
Laurent Perrault‐Sequeira, Michael Pugliese, Rachael MacDonald‐Spracklin, et al.
American Journal on Addictions (2025)
Open Access
Laurent Perrault‐Sequeira, Michael Pugliese, Rachael MacDonald‐Spracklin, et al.
American Journal on Addictions (2025)
Open Access
